Passlogix hits 500,000 user licenses milestone for single sign-on product

Passlogix, a provider of enterprise single sign-on systems, has sold 500,000+ licenses of its v GO Sign-On Platform products into the healthcare industry.
     
The Passlogix v-GO Sign-On Platform, built around v-GO Single Sign-On (v-GO SSO), helps enterprises strengthen security policies and practices, to simplify work processes, reduce costs and to simplify deployments of strong authentication and identity management system, the company said.
     
Besides v-GO SSO, the v-GO Sign-On Platform consists of v-GO Session Manager (v-GO SM) for shared workstations and kiosks, v-GO Self Service Password Reset (v-GO SSPR) for recovering a Windows password, v-GO Authentication Manager (v-GO AM) to enable universal sign-on for strong authenticators and v-GO Provisioning (v-GO PM) Manager for interoperability with all major provisioning systems.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.